Stroke Patients Accrued on Stage 1 of MASTER Trial Benefit From Treatment With Donepezil: Presented at ANA

Posted on October 19th, 2009 by Beth Backus

Doctor's Guide
BALTIMORE, Md -- October 14, 2009 -- Interim data with donepezil administered to patients in the Mayo Acute Stroke Trial to Enhance Recovery (MASTER) supports advancement into stage 2, according to a report presented here at the American Neurological Association (ANA) 134th Annual Meeting.

Tags: Cardiology, Mayo Clinic Jacksonville

You must be logged-in to the site to post a comment.

Contact Us · Privacy Policy